CytoDyn agrees to settle securities class action for $500K cash and 49M shares

CytoDyn Inc.

Settlement in principle: $500,000 cash plus 49 million shares for dismissal of all claims.
Agreement subject to final documentation, court approval, and other conditions.
No admission of fault or liability by CytoDyn; company will defend vigorously if settlement fails.
If unsettled, the securities class action could materially affect financial condition and results.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.